Navigation Links
Baxa Releases Upgrade for DoseEdge™ - the Only Dose Management System With Comprehensive Formulary Management Functionality
Date:11/16/2010

te dose volumes and verify correct product concentrations when an overfill volume is specified.
  • Improved Email Alerts – Notifications have been added that will alert pharmacists that doses are available for remote verification.
  • New Windows Support – DoseEdge now supports Windows 7 Professional on all PrepStations™ and Windows Server 2008 for Local Cache Servers.

  • "DoseEdge is the only dose management software that delivers compounding workflow management and error prevention for such a wide variety of dose types.  Hospitals across the country use DoseEdge to make thousands of safe doses every day," said Larry Gibson, product manager at Baxa Corporation.  "Today's updates enable Directors of Pharmacy to manage pharmacy operations more easily and better utilize their teams to fulfill IV and oral drug preparation demands."

    To view a live demonstration of the DoseEdge Pharmacy Workflow Manager, visit Baxa Corporation in booth #1841 at the ASHP Midyear Clinical Meeting & Exhibition (ASHP), December 5-9th in Anaheim, California.  

    To hear first-hand experiences direct from DoseEdge users, attend an exclusive exhibitor's theatre symposium at ASHP, The Power of Control: Using pharmacy software tools to get control of your workflow, ensure quality control and support patient safety initiatives.  For more information, visit www.baxa.com/safetyinnumbers.

    For more information about Baxa and its industry-leading IV automation products, e-mail info@baxa.com or visit www.baxa.com.

    About Baxa CorporationBaxa, a customer-focused medical device company, provides innovative, solution-based technologies for medication handling and delivery.  Its systems and devices promote t
    '/>"/>

    SOURCE Baxa Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
    2. CEL-SCI Corporation Releases Letter to Shareholders
    3. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
    4. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
    5. Immunosyn Corporation Releases SF-1019 Study Results
    6. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
    7. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
    8. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
    9. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
    10. QRxPharma Releases Additional Phase 3 Data for Q8003IR Dual Opioid Pain Therapy
    11. Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine (MSI-1436) at CBI Obesity Summit
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/2/2015)... SOUTH SAN FRANCISCO, Calif. , March 2, ... therapeutics for the treatment of cancer, today announced ... comprised of leading researchers and clinicians in the ... The new advisory boards will ... its wholly owned pipeline of precision immunotherapies and ...
    (Date:3/2/2015)... , March 2, 2015   Mast ... biopharmaceutical company, today announced preliminary findings from a ... a model of chronic, stable heart failure produced ... study was to examine the effects of repeat ... systolic and diastolic function. Consistent ...
    (Date:3/2/2015)... 2015  Delcath Systems, Inc. (NASDAQ: DCTH ... on oncology with an emphasis on the treatment of ... will participate in the upcoming 27 th Annual ... the Ritz Carlton Laguna Niguel in Dana ... MSN, CRNP, Delcath,s interim President and Chief Executive Officer, ...
    Breaking Medicine Technology:CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 2CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 3Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 2Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 3Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 4Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 5Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 6Delcath To Present At The 27th Annual Roth Conference 2Delcath To Present At The 27th Annual Roth Conference 3
    ... The Epilepsy Foundation recently announced findings that show ... a consistent drug therapy, have a greater chance of ... their medications are switched from one version of an ... brand-to-generic, generic-to-brand or generic-to-generic. See video from the Epilepsy ...
    ... Findings Reinforce March of Dimes Message: Start Taking a ... 11 Women who take folic acid supplements for ... cut their risk of having a premature baby by ... online journal, PLOS Medicine.The study links pre-conceptional folate supplementation ...
    Cached Medicine Technology:VIDEO from Medialink and the Epilepsy Foundation: New Study Suggests Different Versions of the Same Epilepsy Medication Can Be Harmful 2Taking Folic Acid for a Year Before Pregnancy May Reduce Risk of Preterm Birth 2
    (Date:3/2/2015)... YORK, NY (PRWEB) March 02, 2015 This ... off March 2–8 and will provide opportunities for people across ... new ways to help people with MS live their best ... progress made and to inspire others to join the Society’s ... Multiple sclerosis, an unpredictable, often disabling disease of the central ...
    (Date:3/2/2015)... March 02, 2015 Atlantic Information Services, ... AIS’s Directory of Health Plans: 2015 , the ... on the U.S. health plan market, with enrollment data ... United States. , Available as a printed book ... enrollment trends in quick-view tables and charts, as well ...
    (Date:3/2/2015)... Quinta, CA (PRWEB) March 02, 2015 A ... Trades”—Jack Eadon, leader of the 1960s cult rock band Khazad ... fueled by his determination to persevere despite all odds. His ... It,” no matter what situation or goal was before him. ... the ’60s, is now being passed on to a new ...
    (Date:3/2/2015)... The Alliance for Bangladesh Worker Safety today announced ... serve as chief safety officer. In this role, he ... and guide remediation efforts in all factories from which ... the Alliance continues to bring world-class expertise to factory ... said Alliance Independent Chair Ellen Tauscher. “His role as ...
    (Date:3/2/2015)... 2015 Éminence Organic Skin Care, the ... excited to announce the launch of the Balance Collection, ... time-saving solution for those with combination skin. The Balancing ... divided jar to separate the products, consists of the ... Balancing Moisturizer Duo, also in a divided jar, contains ...
    Breaking Medicine News(10 mins):Health News:Every Connection Counts During MS Awareness Week 2Health News:Every Connection Counts During MS Awareness Week 3Health News:Every Connection Counts During MS Awareness Week 4Health News:Now Available from AIS: 12th Edition of Annual Book Containing Health Plan Enrollment Data, Contact Information 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 3Health News:Alliance for Bangladesh Worker Safety Names New Chief Safety Officer 2Health News:Éminence Organic Skin Care Launches Innovative Collection for Combination Skin 2Health News:Éminence Organic Skin Care Launches Innovative Collection for Combination Skin 3
    ... care trends seeking to advance "individualized medicine" are private ... kits, with price tags as high as $2,500, use ... human genome (called "single nucleotide polymorphisms" or "SNPs") associated ... prostate cancer. The U.S. Food and Drug Administration ( ...
    ... patients are given the choice, they are significantly more likely ... of life six months after treatment, compared to a paper ... session, October 5, 2011, at the 53rd Annual Meeting of ... challenges the perception that older cancer patients do not have ...
    ... California, San Diego have developed what they believe to ... biologically benign levels of near infrared (NRI) irradiation, enabling ... The study represents a significant milestone in the area ... Their work is published on line this week ...
    ... Beach, Fla., October 2, 2011 While the majority (70 ... bereaved family and caregivers of their patients who have died, ... in this area during their residency or fellowship, according to ... Meeting of the American Society for Radiation Oncology (ASTRO). , ...
    ... via the Internet may make it easier for cancer patients ... a study conducted by researchers in the Perelman School of ... at the American Society for Radiation Oncology,s (ASTRO) 53rd Annual ... potential way to buoy the low percentage of adult cancer ...
    ... 2011 The Children,s Hospital of Eastern Ontario (CHEO) ... its principal investigators in infectious disease has signed a ... company headquartered in Carlsbad, California, to share information that ... detect the DNA coding for infectious diseases. Dr. Robert ...
    Cached Medicine News:Health News:Study gauges emotional toll of direct-to-consumer genetic testing 2Health News:Cancer patients in their 60s are tech-savvy 2Health News:Polymeric material has potential for noninvasive procedures 2Health News:Most cancer physicians reach out to bereaved family, caregivers 2Health News:Penn-developed online informed consent tool could boost number of patients in cancer clinical trials 2Health News:Global biotech firm partners with CHEO researcher to address a technology gap in infectious disease 2
    Created to simplify stereopsis screening in children. Based on principles of random dots. No glasses are necessary for this stereo test, and the child's eye movement can be easily observed....
    ... versatile new test providing the broadest range ... The Multi-Target Stereo test can be used ... stereopsis, visual attention, form and depth perception, ... includes a pair of high quality reversible ...
    ... These polarized stereo tests provide ... come with a choice of polarized ... thick film lenses slipped into a ... The other choice includes Richmonds new ...
    Comes with seven test plates. Red and green glasses filters are mounted in two frames, one for adults and one for children. Suitable for testing very small children as well as adults....
    Medicine Products: